Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Treatment of Hypertension: Should they be Used Together?

By  

Current Vascular Pharmacology, Vol. 8, Iss. 6, 2010-11 ,pp. : 742-746

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of Effects of Low Dose of Spironolactone and a Thiazide Diuretic in Patients with Hypertension Treated with an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Type 1 Receptor Blocker

By Yutaka Miyashita   Mifune Mizuo   Kubota Eiji   Itoh Hiroshi   Saito Ikuo  

Clinical and Experimental Hypertension, Vol. 31, Iss. 8, 2009-12 ,pp. : 648-656

Informa Healthcare

Access to resources Recommend Favorite

Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995–2002

By Gislason Gunnar   Abildstrom Steen   Rasmussen Jeppe   Rasmussen Søren   Buch Pernille   Gustafsson Ida   Friberg Jens   Gadsbøll Niels   Køber Lars   Stender Steen   Madsen Mette   Torp-Pedersen Christian  

Scandinavian Cardiovascular Journal, Vol. 39, Iss. 1-2, 2005-04 ,pp. : 42-49

Informa Healthcare

Access to resources Recommend Favorite

Is Combined Angiotensin-converting Enzyme Inhibition and Angiotensin Receptor Blockade Associated with Increased Risk of Cardiovascular Death in Hemodialysis Patients?

By  

Current Hypertension Reviews, Vol. 8, Iss. 4, 2012-11 ,pp. : 256-266

Bentham Science Publishers

Access to resources Recommend Favorite

Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients

By Wakabayashi Kana  

Heart and Vessels, Vol. 26, Iss. 3, 2011-05 ,pp. : 252-257

Springer Publishing Company

Access to resources Recommend Favorite